Vol 79, No 5 (2008)

open access

Page views 448
Article views/downloads 1658
Get Citation

Connect on Social Media

Connect on Social Media

Rho kinase – a new target for pharmacological treatment of an overactive bladder

Tomasz Rechberger, Paweł Skorupski, Aneta Adamiak, Andrzej Wróbel
Ginekol Pol 2008;79(5).


Abstract Rho kinase plays a key role in the regulation of smooth muscles contraction, including those of the urinary bladder detrusor. Rho kinase pathway modulates the level of phosphorylation of the myosin light chain, mainly through the inhibition of myosin phosphatase. Recent experimental data indicate that its role might be exacerbated in local and systemic pathological conditions which affect the bladder. It seems that Rho kinase inhibitors, such as Y27632, may turn out to be an effective group of drugs in pharmacotheraphy of an overactive bladder (OAB), which will influence the storage phase of the micturition cycle, without interfering with the physiological voiding.

Article available in PDF format

View PDF Download PDF file